All Stories

  1. Elevated renin activity and change in sleep apnea with primary aldosteronism
  2. Cardiac Hypertrophy and Related Dysfunctions in Cushing Syndrome Patients—Literature Review
  3. Consideration regarding immune checkpoint inhibitor–induced secondary adrenal insufficiency in patients lacking human leucocyte antigen-DR15
  4. Associations of sleep quality, sleep apnea and autonomic function with insulin secretion and sensitivity: HSCAA study
  5. Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study
  6. Overestimation of glomerular filtration rate calculated from serum creatinine as compared with cystatin C in patients with subclinical hypercortisolism: Hyogo Adrenal Metabolic Registry
  7. Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes
  8. Sleep, Autonomic Nervous Function and Atherosclerosis
  9. RAGE and Inflammatory process in endothelial cells
  10. Ectopic adrenocorticotropic hormone syndrome associated with olfactory neuroblastoma: acquirement of adrenocorticotropic hormone expression during disease course as shown by serial immunohistochemistry examinations
  11. Fever of unknown origin following parathyroidectomy prior to onset of typical polymyalgia rheumatica symptoms: a case report
  12. Low sleep quality is associated with progression of arterial stiffness in patients with cardiovascular risk factors: HSCAA study
  13. Hypokalemia associated with pseudo-Cushing’s syndrome and magnesium deficiency induced by chronic alcohol abuse
  14. Plasma brain-derived neurotrophic factor concentration is a predictor of chronic kidney disease in patients with cardiovascular risk factors – Hyogo Sleep Cardio-Autonomic Atherosclerosis study
  15. Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans
  16. Serum Macro TSH Level is Associated with Sleep Quality in Patients with Cardiovascular Risks – HSCAA Study
  17. Plasma leptin concentration is associated with fatigue severity in patients with cardiovascular risk factors – HSCAA study
  18. Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors
  19. Association of Erythropoietin Resistance with Fatigue in Hemodialysis Patients: A Cross-Sectional Study
  20. Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist
  21. Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study
  22. Effects of Nutritional Supplementation on Fatigue, and Autonomic and Immune Dysfunction in Patients with End-Stage Renal Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
  23. Advantage of Insulin Glulisine Over Regular Insulin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
  24. Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study
  25. Anaplastic Thyroid Carcinoma Accompanied by Uncontrollable Eosinophilia
  26. Injectable cell scaffold restores impaired cell-based therapeutic angiogenesis in diabetic mice with hindlimb ischemia
  27. Plasma Brain-Derived Neurotrophic Factor and Reverse Dipping Pattern of Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors
  28. Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: Randomized controlled trial (PioRAGE)
  29. Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
  30. Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes
  31. Kidney Function, Cholesterol Absorption and Remnant Lipoprotein Accumulation in Patients with Diabetes Mellitus
  32. Association Between Glycemic Control and Morning Blood Pressure Surge With Vascular Endothelial Dysfunction in Type 2 Diabetic Patients
  33. Autonomic Function is Associated With Health-Related Quality of Life in Patients With End-Stage Renal Disease: A Case-Control Study
  34. Increased soluble IL-2 receptor levels in serum from a patient with painless thyroiditis
  35. Receptor for Advanced Glycation End Products Regulates Adipocyte Hypertrophy and Insulin Sensitivity in Mice: Involvement of Toll-Like Receptor 2
  36. Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients
  37. AGEs and Cardiovascular Diseases in Patients With End-Stage Renal Diseases
  38. Biochemistry of uridine in plasma
  39. Active Vitamin D and Acute Respiratory Infections in Dialysis Patients
  40. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease
  41. Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus
  42. 21-Hydroxylase Deficiency Associated with Male Infertility: Report of 2 Cases with Gene Analyses
  43. Comparison of the Effect of Cilostazol with Aspirin on Circulating Endothelial Progenitor Cells and Small-Dense LDL Cholesterol in Diabetic Patients with Cerebral Ischemia: A Randomized Controlled Pilot Trial
  44. Different Impacts of Neck Circumference and Visceral Obesity on the Severity of Obstructive Sleep Apnea Syndrome
  45. Fetuin-A is associated with calcified coronary artery disease
  46. Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse
  47. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease
  48. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus
  49. AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?
  50. Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate
  51. Fatigue Is a Predictor for Cardiovascular Outcomes in Patients Undergoing Hemodialysis
  52. Brachial-ankle Pulse Wave Velocity as an Index of Central Arterial Stiffness
  53. Regions of Arterial Stenosis and Clinical Factors Determining Transcutaneous Oxygen Tension in Patients with Peripheral Arterial Disease
  54. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells
  55. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia
  56. Poor Glycemic Control is a Significant Predictor of Cardiovascular Events in Chronic Hemodialysis Patients With Diabetes
  57. Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients
  58. Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice
  59. Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus
  60. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis
  61. The Combination of IMT and Stiffness Parameter .BETA. is Highly Associated with Concurrent Coronary Artery Disease in Type 2 Diabetes
  62. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease
  63. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus
  64. Endogenous Secretory Receptor for Advanced Glycation End-Products and Cardiovascular Disease in End-Stage Renal Disease
  65. RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases
  66. Loss of smooth muscle calponin results in impaired blood vessel maturation in the tumor?host microenvironment
  67. Association of serum fetuin-A with carotid arterial stiffness
  68. Clinical Impact of Metabolic Syndrome by Modified NCEP-ATPIII Criteria on Carotid Atherosclerosis in Japanese Adults
  69. Low Circulating Endogenous Secretory Receptor for AGEs Predicts Cardiovascular Mortality in Patients With End-Stage Renal Disease
  70. Association between Plasma Angiopoietin-Like Protein 3 and Arterial Wall Thickness in Healthy Subjects
  71. Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis
  72. Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin
  73. Body fat mass and lean mass as predictors of survival in hemodialysis patients
  74. Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes
  75. Regional Arterial Stiffness in Patients with Type 2 Diabetes and Chronic Kidney Disease
  76. The association of plasma adiponectin level with carotid arterial stiffness
  77. SREBP inhibits VEGF expression in human smooth muscle cells
  78. Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic Subjects
  79. The Extracellular Matrix Dynamically Regulates Smooth Muscle Cell Responsiveness to PDGFa
  80. Plasma Adiponectin Level Is Associated with Insulin-Stimulated Nonoxidative Glucose Disposal
  81. Regional Arterial Stiffness Associated with Ischemic Heart Disease in Type 2 Diabetes Mellitus
  82. Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis
  83. Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients
  84. Altered relationship between body fat and plasma adiponectin in end-stage renal disease
  85. The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes
  86. Effect of Atorvastatin on Regional Arterial Stiffness in Patients with Type 2 Diabetes Mellitus
  87. Platelet-Monocyte Aggregates are Independently Associated with Occurrence of Carotid Plaques in Type 2 Diabetic Patients
  88. Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: Another form of metabolic syndrome
  89. Short-term aerobic exercise improves arterial stiffness in type 2 diabetes
  90. Effect of Aerobic Exercise on Plasma Adiponectin Levels and Insulin Resistance in Type 2 Diabetes
  91. Arterial stiffness in predialysis patients with uremia
  92. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators
  93. Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population
  94. Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes
  95. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering
  96. Platelet P-Selectin Expression Is Associated With Atherosclerotic Wall Thickness in Carotid Artery in Humans
  97. Blocking of α5 integrin stimulates production of TGF-β and PAI-1 by human mesangial cells
  98. Role of H1-Calponin in Pancreatic AR42J Cell Differentiation Into Insulin-Producing Cells
  99. Preferential Stiffening of Central Over Peripheral Arteries in Type 2 Diabetes
  100. Arterial Wall Thickness is Associated with Insulin Resistance in Type 2 Diabetic Patients
  101. Pulse Wave Velocity in Lower-Limb Arteries among Diabetic Patients with Peripheral Arterial Disease.
  102. Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease
  103. Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration
  104. Lipid Accumulation in Smooth Muscle Cells Under LDL Loading Is Independent of LDL Receptor Pathway and Enhanced by Hypoxic Conditions
  105. Thrombospondin-1 Mediates Smooth Muscle Cell Proliferation Induced by Interaction With Human Platelets
  106. Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells
  107. Insulin Resistance as an Independent Predictor of Cardiovascular Mortality in Patients with End-Stage Renal Disease
  108. The 807T Allele in  2 Integrin Is Protective Against Atherosclerotic Arterial Wall Thickening and the Occurrence of Plaque in Patients With Type 2 Diabetes
  109. Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors
  110. Mönckeberg's medial sclerosis and inorganic phosphate in uremia
  111. Bone resorption associated with uncoupling of osteoclastic and osteoblastic activities in adult T cell leukemia with hypercalcemia: case report
  112. Fibrillar Collagen Specifically Regulates Human Vascular Smooth Muscle Cell Genes Involved in Cellular Responses and the Pericellular Matrix Environment
  113. Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells
  114. Mechanism of atherosclerotic calcification
  115. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation
  116. Distinct Role of cAMP and cGMP in the Cell Cycle Control of Vascular Smooth Muscle Cells
  117. αv Integrin regulates TNF-α-induced nitric oxide synthesis in rat mesangial cells—possible role of osteopontin
  118. Cleavage of p21Cip1/Waf1 and p27Kip1 Mediates Apoptosis in Endothelial Cells through Activation of Cdk2: Role of a Caspase Cascade
  119. Caspase-mediated Cleavage of Focal Adhesion Kinase pp125FAK and Disassembly of Focal Adhesions in Human Endothelial Cell Apoptosis
  120. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets.
  121. Protein Kinase C δ Inhibits the Proliferation of Vascular Smooth Muscle Cells by Suppressing G1Cyclin Expression
  122. Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors
  123. The Fumagillin Analogue TNP-470 Inhibits DNA Synthesis of Vascular Smooth Muscle Cells Stimulated by Platelet-Derived Growth Factor and Insulin-like Growth Factor-I
  124. Phosphorus intake regulates intestinal function and polyamine metabolism in uremia
  125. β-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle Cells
  126. Potentiated 1,25(OH)2D3-induced 24-hydroxylase gene expression in uremic rat intestine
  127. Protein kinase C is involved in 24-hydroxylase gene expression induced by 1,25(OH)2D3 in rat intestinal epithelial cells
  128. Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure
  129. Effect of Uremic Serum on 1,25-Dihydroxyvitamin D3-lnduced Differentiation of Human Promyelocytic Leukemia Cell, HL-60
  130. A new, highly sensitive assay for 1,25-dihydroxyvitamin D not requiring high-performance liquid chromatography: Application of monoclonal antibody against vitamin D receptor to radioreceptor assay
  131. Altered calcium homeostasis accompanying changes of regional bone mineral during a very-low-calorie diet
  132. High-density-lipoprotein metabolism during a very-low-calorie diet
  133. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps
  134. Role of putrescine in interleukin 1? production in human histiocytic lymphoma cell line U937
  135. Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
  136. Lipoprotein Metabolism in Normolipidemic Obese Women during Very Low Calorie Diet
  137. Obesity as a Determinant of Regional Bone Mineral Density
  138. Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry
  139. Measurement of composition changes using dual-photon absorptiometry in obese patients undergoing semistarvation
  140. PLASMA ENDOTHELIN LEVELS IN PATIENTS WITH URAEMIA
  141. Uremic Serum Contains Humoral Factor(s) Larger than Fifty Kilodaltons which Suppresses Endothelin Production in Cultured Endothelial Cells